HER2-Negative Breast Carcinoma Clinical Trials

26 clinical trials for HER2-Negative Breast Carcinoma across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial — RECRUITING · PHASE3
• Neoadjuvant Breast Cancer Time Restricted Eating — RECRUITING · PHASE2
• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer — RECRUITING · PHASE3
• DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs — RECRUITING · PHASE2
• Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer — RECRUITING · PHASE1
• Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer — RECRUITING · PHASE3
• Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer — RECRUITING · PHASE1
• Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer — RECRUITING · NA
• Mobile Health for Adherence in Breast Cancer Patients — RECRUITING · NA
• A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer — RECRUITING · PHASE2
• DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients — RECRUITING
• A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer — RECRUITING · PHASE1
• Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer — RECRUITING · PHASE2
• Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial — RECRUITING · PHASE2
• Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery — RECRUITING · PHASE2
• SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells — RECRUITING · PHASE1
• Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer — RECRUITING · NA
• Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer — RECRUITING
• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial — SUSPENDED · PHASE3
• Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca — ACTIVE_NOT_RECRUITING · PHASE2
• Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer — WITHDRAWN · NA
• A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy — TERMINATED · NA
• Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy — ACTIVE_NOT_RECRUITING · PHASE3

Refine this search